Great Valley Advisor Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.36M Sell
5,816
-7,736
-57% -$3.14M 0.05% 289
2025
Q1
$6.74M Buy
13,552
+1,443
+12% +$718K 0.15% 149
2024
Q4
$6.3M Buy
12,109
+486
+4% +$253K 0.14% 146
2024
Q3
$7.19M Buy
11,623
+739
+7% +$457K 0.18% 127
2024
Q2
$6.02M Buy
10,884
+850
+8% +$470K 0.17% 134
2024
Q1
$5.83M Buy
10,034
+338
+3% +$196K 0.18% 131
2023
Q4
$5.15M Buy
9,696
+1,467
+18% +$779K 0.18% 134
2023
Q3
$4.17M Buy
8,229
+624
+8% +$316K 0.17% 144
2023
Q2
$3.97M Buy
7,605
+813
+12% +$424K 0.17% 149
2023
Q1
$3.91M Sell
6,792
-271
-4% -$156K 0.18% 142
2022
Q4
$3.89M Buy
7,063
+3,214
+84% +$1.77M 0.2% 128
2022
Q3
$1.95M Sell
3,849
-26
-0.7% -$13.2K 0.11% 199
2022
Q2
$2.11M Buy
3,875
+710
+22% +$386K 0.12% 191
2022
Q1
$1.89M Buy
3,165
+526
+20% +$314K 0.11% 200
2021
Q4
$1.75M Buy
2,639
+739
+39% +$491K 0.11% 200
2021
Q3
$1.09M Sell
1,900
-49
-3% -$28K 0.07% 237
2021
Q2
$980K Buy
1,949
+210
+12% +$106K 0.07% 243
2021
Q1
$794K Buy
1,739
+291
+20% +$133K 0.08% 224
2020
Q4
$675K Buy
1,448
+102
+8% +$47.5K 0.07% 237
2020
Q3
$594K Sell
1,346
-188
-12% -$83K 0.07% 218
2020
Q2
$557K Sell
1,534
-17
-1% -$6.17K 0.09% 218
2020
Q1
$440K Sell
1,551
-225
-13% -$63.8K 0.12% 188
2019
Q4
$577K Buy
1,776
+230
+15% +$74.7K 0.13% 189
2019
Q3
$450K Buy
1,546
+109
+8% +$31.7K 0.11% 205
2019
Q2
$422K Sell
1,437
-87
-6% -$25.5K 0.11% 203
2019
Q1
$417K Buy
1,524
+85
+6% +$23.3K 0.13% 176
2018
Q4
$322K Buy
+1,439
New +$322K 0.12% 154